Skip to main content

Peer Review reports

From: Lumacaftor/ Ivacaftor improves exercise tolerance in patients with Cystic Fibrosis and severe airflow obstruction

Original Submission
14 Jul 2018 Submitted Original manuscript
21 Jan 2019 Author responded Author comments - Peter Wark
12 Sep 2018 Reviewed Reviewer Report - Elena K. Schneider
1 Oct 2018 Reviewed Reviewer Report - Anthony Fischer
Resubmission - Version 2
21 Jan 2019 Submitted Manuscript version 2
21 Mar 2019 Author responded Author comments - Peter Wark
30 Jan 2019 Reviewed Reviewer Report - Elena K. Schneider
12 Feb 2019 Reviewed Reviewer Report - Anthony Fischer
Resubmission - Version 3
21 Mar 2019 Submitted Manuscript version 3
13 May 2019 Author responded Author comments - Peter Wark
9 Apr 2019 Reviewed Reviewer Report - Anthony Fischer
Resubmission - Version 4
13 May 2019 Submitted Manuscript version 4
24 May 2019 Author responded Author comments - Peter Wark
Resubmission - Version 5
24 May 2019 Submitted Manuscript version 5
Publishing
29 May 2019 Editorially accepted
17 Jun 2019 Article published 10.1186/s12890-019-0866-y

You can find further information about peer review here.

Back to article page